<DOC>
	<DOCNO>NCT02800837</DOCNO>
	<brief_summary>Prospective , non-randomized , multi-center study assess long term safety efficacy self expandable sirolimus elute Xposition S stent treatment unprotected leave main coronary artery disease .</brief_summary>
	<brief_title>Clinical Study Evaluate STENTYS Xposition S Treatment Unprotected Left Main Coronary Artery Disease</brief_title>
	<detailed_description>In treatment unprotected leave main coronary artery ( ULMCA ) disease , previous mono-center study show promising result previous generation self-expandable STENTYS stent ( paclitaxel elute stent , deliver via withdrawal sheath ) . The TRUNC study aim assess large scale Xposition S treatment ULMCA disease . The Xposition S sirolimus elute stent , mount balloon delivery system . The study aim collect clinical practice routine data 200 patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Main Subject ≥ 18 year old ; Presence coronary artery stenosis unprotected Left Main ( LM ) Coronary Artery indicate PCI Xposition S stent treatment Left Main Coronary Artery reference vessel diameter range 2.5 mm 6.0 mm ; The subject able provide voluntary informed consent , willing comply study requirement sign write informed consent . Main Recent STEMI ( &lt; 1 month ) ; SYNTAX score ≥ 33 ; Highly calcify lesion excessive tortuosity target lesion site ; Subject unable comply dual antiplatelet therapy recommend per guideline ; Planned cardiac surgery valve intervention within next 12 month . Participation investigational drug device study reach primary endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>left main</keyword>
	<keyword>stent</keyword>
	<keyword>self-expandable</keyword>
	<keyword>DES</keyword>
	<keyword>Stentys</keyword>
</DOC>